These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7726975)

  • 1. Omeprazole and the metabolism of caffeine.
    Andersson T; Eriksson S; Walan A; Hässle A
    Am J Gastroenterol; 1995 Mar; 90(3):515-8. PubMed ID: 7726975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Omeprazole. Its pharmacology and therapeutic efficacy].
    Protzer U; Holtermüller KH
    Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
    [No Abstract]   [Full Text] [Related]  

  • 3. [New antisecretory drugs in the treatment of ulcer].
    Sheptulin AA
    Klin Med (Mosk); 1994; 72(1):12-5. PubMed ID: 7910870
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Italian pilot experience with omeprazole. Preliminary pharmacologic and clinical results].
    Bertaccini G; Cisternino M; Coruzzi G; Francavilla A; Gallazzi M; Ingrosso M; Labò G; Rinetti M; Sivelli R; Tomassetti P
    Clin Ter; 1987 May; 121(3):201-7. PubMed ID: 2956010
    [No Abstract]   [Full Text] [Related]  

  • 5. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole.
    Marinos Y; Honson K
    Aust Nurses J; 1991 Aug; 21(2):29-30. PubMed ID: 1953494
    [No Abstract]   [Full Text] [Related]  

  • 7. Omeprazole in gastric and duodenal ulcers.
    Savarino V; Mela GS; Celle G
    Gut; 1991 Jun; 32(6):721. PubMed ID: 2060885
    [No Abstract]   [Full Text] [Related]  

  • 8. Four-week treatment with omeprazole increases the metabolism of caffeine.
    Nousbaum JB; Berthou F; Carlhant D; Riche C; Robaszkiewicz M; Gouerou H
    Am J Gastroenterol; 1994 Mar; 89(3):371-5. PubMed ID: 8122647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
    Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
    Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
    [No Abstract]   [Full Text] [Related]  

  • 10. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness and pharmacokinetics of omeprazole in children with refractory duodenal ulcer.
    Kato S; Shibuya H; Hayashi Y; Tseng SW; Nakagawa H; Ohi R
    J Pediatr Gastroenterol Nutr; 1992 Aug; 15(2):184-8. PubMed ID: 1403468
    [No Abstract]   [Full Text] [Related]  

  • 12. [Omeprazole. Antiulcer and gastric anti-secretory agent: one of the most prescribed drugs in France].
    Taeron C
    Rev Infirm; 2002 Oct; (84):49-50. PubMed ID: 12432644
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is gastric and duodenal ulcer drug-treatable or surgical disease?].
    Fedele E
    Chir Ital; 1997; 49(1-2):5-8. PubMed ID: 12743869
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of bleeding peptic ulcers with omeprazole.
    Munkel L; French L
    J Fam Pract; 1997 Jul; 45(1):20-1. PubMed ID: 9228906
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
    Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
    Gabryelewicz A; Laszewicz W; Dzieniszewski J; Ciok J; Marlicz K; Bielecki D; Popiela T; Legutko J; Knapik Z; Poniewierka E
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():93-105. PubMed ID: 9440060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastroduodenitis and ulcers--statistical study for 1998].
    Vichev E; Krŭstev N; Krŭstev D; Baeva N; Kiselova A; Ianev N
    Vutr Boles; 2000; 32(3):37-8. PubMed ID: 11688321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.